DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449–62.

Article  PubMed  PubMed Central  Google Scholar 

Kawasaki E, Maruyama T, Imagawa A, Awata T, Ikegami H, Uchigata Y, et al. Diagnostic criteria for acute-onset type 1 diabetes mellitus (2012): report of the Committee of Japan Diabetes Society on the research of fulminant and acute-onset Type 1 Diabetes Mellitus. J Diabetes Investig. 2014;5:115–8.

Article  CAS  PubMed  Google Scholar 

Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331:1480–91.

Article  CAS  PubMed  Google Scholar 

Noble JA. Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun. 2015;64:101–12.

Article  CAS  PubMed  Google Scholar 

Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia. 2009;52:2513–21.

Article  CAS  PubMed  Google Scholar 

Christen U, von Herrath MG. Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference? Cell Mol Immunol. 2011;8:193–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet. 2016;387:2340–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aida K, Nishida Y, Tanaka S, Maruyama T, Shimada A, Awata T, et al. RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes. Diabetes. 2011;60:884–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, et al. Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes. Diabetes. 2009;58:2285–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lombardi A, Tsomos E, Hammerstad SS, Tomer Y. Interferon alpha: the key trigger of type 1 diabetes. J Autoimmun. 2018;94:7–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16:S27-36.

Article  PubMed  PubMed Central  Google Scholar 

Noubiap JJ, Nansseu JR, Nyaga UF, Nkeck JR, Endomba FT, Kaze AD, et al. Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2·3 million patients with tuberculosis. Lancet Glob Health. 2019;7:e448–60.

Article  PubMed  Google Scholar 

Sechi LA, Paccagnini D, Salza S, Pacifico A, Ahmed N, Zanetti S. Mycobacterium avium subspecies paratuberculosis bacteremia in type 1 diabetes mellitus: an infectious trigger? Clin Infect Dis. 2008;46:148–9.

Article  PubMed  Google Scholar 

Dow CT. Paratuberculosis and Type I diabetes: is this the trigger? Med Hypotheses. 2006;67:782–5.

Article  PubMed  Google Scholar 

Rosu V, Ahmed N, Paccagnini D, et al. Specific immunoassays confirm association of Mycobacterium avium Subsp. paratuberculosis with type-1 but not type-2 diabetes mellitus. PLoS ONE. 2009;4:e4386.

Article  PubMed  PubMed Central  Google Scholar 

Paccagnini D, Sieswerda L, Rosu V, et al. Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS ONE. 2009;4:e7109.

Article  PubMed  PubMed Central  Google Scholar 

O’Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475–527.

Article  CAS  PubMed  Google Scholar 

Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125:S3-23.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi K, Satoh J, Kojima Y, et al. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese. Tissue Antigens. 2004;63:231–6.

Article  CAS  PubMed  Google Scholar 

Nishino M, Ikegami H, Fujisawa T, et al. Functional polymorphism in Z-DNA-forming motif of promoter of SLC11A1 gene and type 1 diabetes in Japanese subjects: association study and meta-analysis. Metabolism. 2005;54:628–33.

Article  CAS  PubMed  Google Scholar 

Yang JH, Downes K, Howson JM, et al. Evidence of association with type 1 diabetes in the SLC11A1 gene region. BMC Med Genet. 2011;12:59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meilang Q, Zhang Y, Zhang J, et al. Polymorphisms in the SLC11A1 gene and tuberculosis risk: a meta-analysis update. Int J Tuberc Lung Dis. 2012;16:437–46.

Article  CAS  PubMed  Google Scholar 

Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78:1151–9.

Article  PubMed  Google Scholar 

Günaydin I, Daikeler T, Mohren M, Kanz L, Kötter I. Lower limb pitting edema in systemic lupus erythematosus. Rheumatol Int. 1999;18:159–60.

Article  PubMed  Google Scholar 

Rajasekhar L, Habibi S, Sudhakar P, Gumdal N. Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus. Clin Rheumatol. 2013;32:S11–3.

Article  PubMed  Google Scholar 

Khan A, Mouhydeen H, Gharib H. Systemic lupus erythematosus flare masquerading as bilateral lower extremity non-pitting edema: a case report. Cureus. 2023;15:e48344.

PubMed  PubMed Central  Google Scholar 

Illescas-Montes R, Corona-Castro CC, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology. 2019;158:153–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimane K, Kochi Y, Suzuki A, Okada Y, Ishii T, Horita T, et al. An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes. Rheumatology (Oxford). 2013;52:1172–82.

Article  CAS  PubMed  Google Scholar 

Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, et al. Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;47:38–45.

Article  PubMed  Google Scholar 

Ongarj J, Intapiboon P, Surasombatpattana S, et al. Evaluation of immune profiles associated with control of mycobacterial growth in systemic lupus erythematosus (SLE) patients. Tuberculosis (Edinb). 2024;148:102533.

Article  CAS  PubMed  Google Scholar 

Popoviciu MS, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S. Type 1 Diabetes Mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine. J Pers Med. 2023;13:422.

Article  PubMed  PubMed Central